Literature DB >> 453612

Hypertension during anesthesia on discontinuation of sodium nitroprusside-induced hypotension.

H J Khambatta, J G Stone, E Khan.   

Abstract

The authors had observed that on intraoperative discontinuation of sodium nitroprusside being administered to induce hypotension, mean arterial pressure increased to above the pre-hypotension level. Twelve patients who recieved hypotensive anesthesia for surgical correction of cerebral aneurysms were studied to evaluate the role of the renin-angiotensin system in this phenomenon. In the awake state, mean arterial pressure was 100 +/- 2 torr and plasma renin activity 3.0 +/- 0.1 ng/ml/hr. Thirty minutes after the establishment of stable halothane-nitrous oxide anesthesia, mean arterial pressure decreased to 85 +/- 1 torr and plasma renin activity increased to 4.4 +/- 0.1 ng/ml/hr. No appreciable change in either occurred over the next two hours of operation. During sodium nitroprusside-induced hypotension, mean arterial pressure decreased to 49 +/- 2 torr and plasma renin activity increased to 15.2 +/- 0.2 ng/ml/hr. Thirty minutes after discontinuation of sodium nitroprusside administration, mean arterial pressure increased to 112 +/- 2 torr, which was not only higher than the prehypotension level, but also significantly higher than that recorded in the awake state. Plasma renin activity at that time was 10.9 +/- 0.1 ng/ml/hr. As the half-life of plasma renin is 15 min, the data suggest that the persistently increased plasma renin activity is probably responsible for the increase of arterial pressure following sodium nitroprusside-induced hypotension.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 453612     DOI: 10.1097/00000542-197908000-00007

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  18 in total

1.  Hemodynamic effects of KRN2391 (potassium channel opener) in halothane-anesthetized dogs.

Authors:  Shohei Takeda; Yutaka Inada; Yoshiki Ozawa; Narue Nakamizo; Teruaki Tomaru
Journal:  J Anesth       Date:  1995-06       Impact factor: 2.078

2.  A correlation of catecholamine and vasoactive Peptide release with hemodynamics in patients undergoing resection of arteriovenous malformations.

Authors:  Eric L Bloomfield; Michelle Secic; David Porembka
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  Plasma catecholamines, plasma renin activity and haemodynamics during sodium nitroprusside-induced hypotension and additional beta-blockage with bunitrolol.

Authors:  B Stanek; M Zimpfer; S Fitzal; G Raberger
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  Treatment of perioperative hypertension: Is clevidipine the answer?

Authors:  Joseph D Tobias
Journal:  Saudi J Anaesth       Date:  2009-07

5.  Arterial and transcutaneous oxygen tension measurement during hypotensive anaesthesia.

Authors:  N El Mikatti
Journal:  Ann R Coll Surg Engl       Date:  1982-09       Impact factor: 1.891

6.  Intra-operative blood pressure control by prostaglandin E1 in patients with hypertension and ischemic heart disease--a multi-center study.

Authors:  S Hoka; J Yoshitake; K Dan; Y Goto; N Honda; T Morioka; T Muteki; Y Okuda; A Shigematsu; M Takasaki; T Totoki; N Yoshimura
Journal:  J Anesth       Date:  1993-04       Impact factor: 2.078

Review 7.  Controlled hypotension: a guide to drug choice.

Authors:  Christian-Serge Degoute
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  The stress response to induced hypotension for cerebral aneurysm surgery: a comparison of two hypotensive techniques.

Authors:  M S Macnab; P H Manninen; A M Lam; A W Gelb
Journal:  Can J Anaesth       Date:  1988-03       Impact factor: 5.063

Review 9.  Controlled hypotension in children: a critical review of available agents.

Authors:  Joseph D Tobias
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

10.  Parenteral clevidipine for the acute control of blood pressure in the critically ill patient: a review.

Authors:  W Frank Peacock; Jorge E Angeles; Karina M Soto; Philip D Lumb; Joseph Varon
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.